428 related articles for article (PubMed ID: 16622294)
1. Insulin resistance and improvements in signal transduction.
Musi N; Goodyear LJ
Endocrine; 2006 Feb; 29(1):73-80. PubMed ID: 16622294
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
[TBL] [Abstract][Full Text] [Related]
3. Exercise training-induced improvements in insulin action.
Hawley JA; Lessard SJ
Acta Physiol (Oxf); 2008 Jan; 192(1):127-35. PubMed ID: 18171435
[TBL] [Abstract][Full Text] [Related]
4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
5. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase in metabolic control and insulin signaling.
Towler MC; Hardie DG
Circ Res; 2007 Feb; 100(3):328-41. PubMed ID: 17307971
[TBL] [Abstract][Full Text] [Related]
7. AMP-activated protein kinase: Role in metabolism and therapeutic implications.
Schimmack G; Defronzo RA; Musi N
Diabetes Obes Metab; 2006 Nov; 8(6):591-602. PubMed ID: 17026483
[TBL] [Abstract][Full Text] [Related]
8. Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.
Longnus SL; Ségalen C; Giudicelli J; Sajan MP; Farese RV; Van Obberghen E
Diabetologia; 2005 Dec; 48(12):2591-601. PubMed ID: 16283248
[TBL] [Abstract][Full Text] [Related]
9. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
10. Muscle fiber type-specific defects in insulin signal transduction to glucose transport in diabetic GK rats.
Song XM; Kawano Y; Krook A; Ryder JW; Efendic S; Roth RA; Wallberg-Henriksson H; Zierath JR
Diabetes; 1999 Mar; 48(3):664-70. PubMed ID: 10078575
[TBL] [Abstract][Full Text] [Related]
11. Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.
Kumar N; Dey CS
Br J Pharmacol; 2002 Oct; 137(3):329-36. PubMed ID: 12237252
[TBL] [Abstract][Full Text] [Related]
12. Sending the signal: molecular mechanisms regulating glucose uptake.
Krook A; Wallberg-Henriksson H; Zierath JR
Med Sci Sports Exerc; 2004 Jul; 36(7):1212-7. PubMed ID: 15235328
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.
Winder WW; Hardie DG
Am J Physiol; 1999 Jul; 277(1):E1-10. PubMed ID: 10409121
[TBL] [Abstract][Full Text] [Related]
14. Insulin-independent pathways mediating glucose uptake in hindlimb-suspended skeletal muscle.
Hilder TL; Baer LA; Fuller PM; Fuller CA; Grindeland RE; Wade CE; Graves LM
J Appl Physiol (1985); 2005 Dec; 99(6):2181-8. PubMed ID: 16099889
[TBL] [Abstract][Full Text] [Related]
15. Role of AMP--activated protein kinase in the control of glucose homeostasis.
Barnes BR; Zierath JR
Curr Mol Med; 2005 May; 5(3):341-8. PubMed ID: 15892653
[TBL] [Abstract][Full Text] [Related]
16. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
[TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle.
Lee WJ; Song KH; Koh EH; Won JC; Kim HS; Park HS; Kim MS; Kim SW; Lee KU; Park JY
Biochem Biophys Res Commun; 2005 Jul; 332(3):885-91. PubMed ID: 15913551
[TBL] [Abstract][Full Text] [Related]
18. Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo.
Neschen S; Katterle Y; Richter J; Augustin R; Scherneck S; Mirhashemi F; Schürmann A; Joost HG; Klaus S
Physiol Genomics; 2008 May; 33(3):333-40. PubMed ID: 18349383
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
[TBL] [Abstract][Full Text] [Related]
20. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
Musi N; Hirshman MF; Nygren J; Svanfeldt M; Bavenholm P; Rooyackers O; Zhou G; Williamson JM; Ljunqvist O; Efendic S; Moller DE; Thorell A; Goodyear LJ
Diabetes; 2002 Jul; 51(7):2074-81. PubMed ID: 12086935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
